ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,955Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 45

$954K Total Retail Price of All Prescriptions

Rank: 9 out of 45

651 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

42% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

3% of this provider’s 11,514 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,983 1,075 S3 1 1
LISINOPRIL 779 428 2 2
SIMVASTATIN 497 365 3 4
FUROSEMIDE 488 313 4 6
OMEPRAZOLE 468 303 5 3
METOPROLOL TARTRATE 448 322 6 10
GABAPENTIN 438 194 7 9
LEVOTHYROXINE SODIUM 350 230 8 5
NEXIUM 349 137 9 19
RANITIDINE HCL 335 175 10 16
AMLODIPINE BESYLATE 322 221 11 7
HYDROCHLOROTHIAZIDE 292 182 12 11
METFORMIN HCL 282 159 13 8
CLOPIDOGREL 240 138 14 26
POTASSIUM CHLORIDE 233 171 15 13
ISOSORBIDE MONONITRATE ER 222 177 16 30
ZOLPIDEM TARTRATE 220 108 17 22
ATENOLOL 219 151 18 15
CITALOPRAM HBR 213 132 19 21
PROAIR HFA 199 89 20 38
PLAVIX 199 140 20 35
TRAMADOL HCL 193 120 22 20
TRIAMTERENE-HCTZ 170 108 23 46
IBUPROFEN 162 71 24 40
CARVEDILOL 161 106 25 25
PROMETHAZINE HCL 160 67 R 26 33
GLIPIZIDE 157 107 27 56
DIOVAN 155 129 28 43
SERTRALINE HCL 153 101 29 24
KLOR-CON 10 142 99 30 117
NAPROXEN 141 71 31 65
CYCLOBENZAPRINE HCL 129 37 R 32 45
LACTULOSE 128 118 33 81
CEPHALEXIN 126 58 34 81
FAMOTIDINE 124 74 35 127
OXYCODONE HCL-ACETAMINOPHEN 116 49 S2 36 94
DILTIAZEM 24HR CD 114 61 37 130
DONEPEZIL HCL 111 111 38 37
MIRTAZAPINE 110 75 39 58
TAMSULOSIN HCL 110 59 39 34
COMBIVENT 109 58 41 109
LANTUS 109 86 41 60
WARFARIN SODIUM 102 75 43 17
CLONIDINE HCL 100 50 44 61
SPIRIVA 98 32 45 54
ALLOPURINOL 98 69 45 36
PREDNISONE 98 66 45 52
AMOXICILLIN 95 54 48 63
ATORVASTATIN CALCIUM 91 47 49 12
MECLIZINE HCL 90 56 50 73
ACETAMINOPHEN-CODEINE 90 58 S3 50 66
BACLOFEN 87 32 52 105
POLYETHYLENE GLYCOL 3350 84 82 53 53
VENTOLIN HFA 83 26 54 68
FLUTICASONE PROPIONATE 82 52 55 44
TIZANIDINE HCL 82 24 55 41
ADVAIR DISKUS 81 38 57 70
AZITHROMYCIN 78 45 58 39
DOXYCYCLINE HYCLATE 76 50 59 104
THEOPHYLLINE ANHYDROUS 75 46 60 121
METOPROLOL SUCCINATE 75 40 60 18
NAMENDA 73 73 62 57
MELOXICAM 73 41 62 28
SINGULAIR 72 51 64 79
ENDOCET 71 16 S2 65 90
LYRICA 68 42 66 99
SOTALOL 63 53 67 235
NITROSTAT 63 44 67 128
CRESTOR 62 43 69 23
FLUOXETINE HCL 61 36 70 47
HYDRALAZINE HCL 58 45 71 108
KLOR-CON M10 57 44 72 147
METHOCARBAMOL 57 0 R 72 126
NASONEX 57 44 72 137
LANSOPRAZOLE 57 19 72 98
LEVOFLOXACIN 56 36 76 136
HYDROXYZINE PAMOATE 54 34 R 77 88
PREMARIN 53 12 R 78 190
ACTOS 53 33 78 115
AMITRIPTYLINE HCL 52 24 R 80 42
DIGOXIN 50 47 81 78
FENTANYL 50 29 S2 81 141
PAROXETINE HCL 50 31 81 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.